Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 496
Selected: 0
NCT IDTitle
NCT04205903Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer
NCT06205394Improving The Breast Cancer Care Delivery Model for Sex and Gender Minority Survivors, Intended for SGM Study
NCT03492151Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
NCT04781088Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT01975363Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer
NCT03858855Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment
NCT05786040Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder
NCT04836832Acalabrutinib and Duvelisib for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
NCT02299518Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT05048108Remote Assessment of Cognition, Insulin Resistance and Omega-3 Fatty Acid Biomarkers in Breast Cancer Survivors
NCT00323323CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas
NCT05198089Development of a Digital Tool, MyInspiration, for the Improvement of Spiritual Well-Being in Patients with Cancer
NCT01801059Patient Activation Intervention in Improving Screening Rates for Colorectal Cancer
NCT00589550PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer
NCT00201682Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
NCT01814501Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
NCT00989586Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
NCT03307044Fractional CO2 Laser Therapy for Survivors of Breast Malignancies
NCT03372720Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors
NCT00824733Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer
NCT04954885Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity
NCT00230126OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer
NCT06470971Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial
NCT05178498Impact of Dietary Inflammatory Potential on Breast Cancer Risk
NCT01129206Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy
NCT04602026The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer
NCT04848064Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
NCT00201799Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation
NCT06644664Nicotine and Tobacco Message Framing to Change Smoking Behavior in Diverse Groups of Young Adult Smokers
NCT02035527Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT04049539Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction
NCT02351505Selinexor in Treating Patients With Relapsed Small Cell Lung Cancer
NCT05453773Hookah Additive Research to Inform Product Standards
NCT00566540Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer
NCT01521039Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease
NCT01904656CBPR Strategies to Increase Colorectal Cancer Screening in Ohio Appalachia
NCT02835755Mobile Health Intervention in Increasing HPV Vaccine Coverage Among Young Adult Gay and Bisexual Men
NCT02262325Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery
NCT00201747Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer
NCT04597086Bright White Light Therapy for the Improvement of Sleep, Fatigue, Distress, Depression, and Anxiety in Hospitalized Leukemia Patients
NCT04120454Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer
NCT02942524Checklist Tool in Engaging Patients in the Discharge Planning Process
NCT01372917Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction Study
NCT05012176An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors
NCT00201838Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma
NCT05418088Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies
NCT02122081Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
NCT05665725Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma
NCT02837887Computerized Cognitive Behavior Therapy in Treating Depression in Patients With Cancer
NCT01764789Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer